AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2021
May 13, 2021
30042_dirs_2021-05-12_08b8a4ea-4604-414e-99d3-a064d3a8ad9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-11
Reporting Person: SELLERS ROBERT W.A. (VP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-11 | Common Stock | F | 274.0000 | $90.4000 | Disposed | 10759.6925 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20409.0000 | Indirect |
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 8
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17